HofmannR,BenzEJ,ShattilSJ,FurieB,SilbersteinLE,McGlaveP,HeslopLEE, 2009.,Hematology: Basic Principies and Practice -
WeatherallDJ,CleggJB, 2001.Inherited haemoglobin disorders: an increasing global health problem,Bull World Health Organ 79 704 -12
TripodiA,CappelliniMD,ChantarangkulV,PadovanL,FasuloMR,MarconA, 2009.Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in plateletpoor plasma,Haematologica 94 1520 -7
YasmeenH,TomaS,KilleenN,HasnainS,ForoniL, 2016.The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population,Eur J Med Genet 59 355 -62
DussiotM,MacielTT,FricotA,ChartierC,NegreO,VeigaJ, 2014.An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia,Nat Med 20 398 -407
CollenD,SchetzJ,de Cock , F,E , Verstraete,M., 1977.Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration,Eur J Clin Invest 7 27 -35
SirachainanN,ThongsadJ,PakakasamaS,HongengS,ChuansumritA,KadegasemP, 2012.Normalized coagulation markers and anticoagulation proteins in children with severe ß- thalassemia sease after stem cell transplantation,Thromb Res 129 765 -70
TurkB,BrieditisI,BockSC,OlsonST,BjörkI., 1997.The oligosaccharide side chain on Asn-135 of α-antithrombin, absent in β-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change,Biochem 36 6682 -91
YangX,AlexanderKP,ChenAY,RoeMT,RG , Rao,SV, 2005.The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative,J Am Coll Cardiol 46 1490 -5
BullerHR, 1989.Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate,Am J Med 87 44 -8S
InthornD,HoffmannJN,HartlWH,MühlbayerD,JochumM. Antithrombin, 1997.III supplementation in severe sepsis: beneficial effects on organ dysfunction,Shock 8 328 -34
Chang , W,MR , Lomas,DA , Carrell,RW, 1996.Probing serpin reactive-loop conformations by proteolytic cleavage,Biochem J 314 647 -53
LaneDA,KunzG,OldsRJ,TheinSL, 1996.Molecular genetics of antithrombin deficiency,Blood Rev 10 59 -74
MaherCA,OldsT,WilliamsMT,LaneAE, 2008.Self-reported quality of life in adolescents with cerebral palsy,Phys Occup Ther Pediatr 28 41 -57
SasG, 1984.Hereditary antithrombin III deficiency: biochemical aspects,Haematologia (Budap) 17 81 -6
HameedA,HussainA,FayyazT,TayyabM,AhmadJ, 2002.Chronic liver disease assessment of antithrombin III level,Professional Med J 9 100 -5
ShoaibM,ShamsiT,NazA, 2008.Arteriovenous thrombosis in chronic renal patients receiving renal replacement therapy,J Coll Physicians Surg Pak 18 418 -23
OldsRJ,LaneDA,ChowdhuryV,De StefanoV,LeoneG,TheinSL, 1993.Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia,Biochem 32 4216 -24
RahmaniMTH,TayyabM,TasneemT., 1999.Plasma antithrombin III levels in Pakistani women with pre-eclampsia,J Ayub Med Coll Abbottabad 11 20 -3
SheikhMA,MemonI,GhoriRA, 2010.Frequency of anemia in patients with systemic lupus erythromatosis at tertiary care hospital,J Pak Med Assoc 60 822 -5
EldorA,DurstR,Hy-AmE,GoldfarbA,GillisS,RachmilewitzEA, 1999.A chronic hypercoagulable state in patients with betathalassaemia major is already present in childhood,Br J Haematol 107 739 -46
YasharVBB,BarenholtzY,Hy-AmE,RachmilewitzEA,EldorA, 1993.Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes,Am J Hematol 44 63 -5
CappelliniMD,CoppolaR,RobbioloL,GraziadeiG,ValentiniM,AriensRAS, 1996.Procoagulant activity of erythrocytes in thalassemia intermedia,Blood 88 38a -